Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa.

"The authors have no funding or conflicts of interest to disclose."

"The authors thank the Ministry of Health in all participating countries for their partnership and support with the respective NGOs and BIPAI Network endeavors. The authors would also like to thank the Executive Directors at each participating NGO, the BIPAI Network leadership, and M&E teams for their continued support. The authors want to offer their gratitude to all programmatic funders and implementing partners across the BIPAI and our amazingly talented and dedicated staff working tirelessly at the COEs to provide truly excellent care. And of course, the authors thank the brave children and adolescents living with HIV receiving care for being a continuous source of inspiration, resilience, and hope to all the BIPAI staff. The authors thank the Ministry of Health in all participating countries for their partnership and support with the respective NGOs and BIPAI Network endeavors. The authors would also like to thank the Executive Directors at each participating NGO, the BIPAI Network leadership, and M&E teams for their continued support. The authors want to offer their gratitude to all programmatic funders and implementing partners across the BIPAI and our amazingly talented and dedicated staff working tirelessly at the COEs to provide truly excellent care. And of course, the authors thank the brave children and adolescents living with HIV receiving care for being a continuous source of inspiration, resilience, and hope to all the BIPAI staff. The authors have no funding or conflicts of interest to disclose."